More on CVS Caremark (CVS): Retail pharmacy sales rose 4.3% with higher drug costs and the...

|About: CVS Health Corporation (CVS)|By:, SA News Editor

More on CVS Caremark (CVS): Retail pharmacy sales rose 4.3% with higher drug costs and the growth of the firm's Medicare Part D program contributing. The company raises and narrows its full-year guidance to $3.38-$3.41, from a prior range of $3.32-$3.38. (PR)